Fostamatinib Phase 3 Data Published in American Journal of Hematology

Positive results from the Fostamatinib in Thrombocytopenia (FIT) Phase 3 clinical program of fostamatinib disodium hexahydrate (Tavalisse) were published in the American Journal of Hematology this week for the treatment of adults with chronic immune thrombocytopenia...

Developing Clinical Trials for Rett Syndrome

  Stefan Weber, CEO of Newron Pharmaceuticals discusses his company’s clinical trial strategy for developing drugs for Rett Syndrome. Newron is focused on the development of novel therapies for patients with diseases of the central and peripheral nervous...

Clinical Studies of Lenabasum for Systemic Sclerosis

  Yuval Cohen, PhD, CEO of Corbus discusses current clinical trials of lenabasum for systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis. Lenabasum is a synthetic, oral, small-molecule, selective cannabinoid receptor type 2...
  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.